Key processes in CKD underlying the development of anemia are erythropoietin (EPO) deficiency and functional iron deficiency (FID), typically managed with use of iron, blood transfusion, or administration of an exogenous ESA. The gene discussed is EPO; the disease is anemia (phenotype).